Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Pedersen

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Journal of Crohn'S & Colitis|October 9, 2020
Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort StudyMohamed Attauabi, Anja Poulsen, Klaus Theede, et al.
Digestive Diseases and Sciences|November 14, 2024
Comparing Environmental Risk Factors at Diagnosis in Faroese and Danish Patients with Inflammatory Bowel DiseaseKári Rubek Nielsen, Frederikke Agerbo Modin, Jóngerð Midjord, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005Ida Vind, Lene Riis, Cathrine Jespersgaard, et al.
Plos One|December 25, 2015
Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish CohortSteffen Bank, Paal Skytt Andersen, Johan Burisch, et al.
Danish Medical Journal|March 10, 2015
Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseasesSteffen Bank, Paal Skytt Andersen, Johan Burisch, et al.
Plos One|June 28, 2014
Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohortSteffen Bank, Paal Skytt Andersen, Johan Burisch, et al.
Scandinavian Journal of Gastroenterology|July 5, 2021
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseasesMohamed Attauabi, Camilla Höglund, Janne Fassov, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up studyKonstantinos H Katsanos, Athina Tatsioni, Natalia Pedersen, et al.
Journal of Crohn'S & Colitis|January 12, 2021
Course of Disease in Patients with Microscopic Colitis: A European Prospective Incident Cohort StudyBas P M Verhaegh, Andreas Münch, Danila Guagnozzi, et al.
Journal of Crohn'S & Colitis|November 10, 2021
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level DataMohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Journal of Crohn'S & Colitis|October 9, 2020
Prevalence and Outcomes of COVID-19 Among Patients With Inflammatory Bowel Disease-A Danish Prospective Population-based Cohort StudyMohamed Attauabi, Anja Poulsen, Klaus Theede, et al.
Digestive Diseases and Sciences|November 14, 2024
Comparing Environmental Risk Factors at Diagnosis in Faroese and Danish Patients with Inflammatory Bowel DiseaseKári Rubek Nielsen, Frederikke Agerbo Modin, Jóngerð Midjord, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Genetic and environmental factors as predictors of disease severity and extent at time of diagnosis in an inception cohort of inflammatory bowel disease, Copenhagen County and City 2003-2005Ida Vind, Lene Riis, Cathrine Jespersgaard, et al.
Plos One|December 25, 2015
Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish CohortSteffen Bank, Paal Skytt Andersen, Johan Burisch, et al.
Danish Medical Journal|March 10, 2015
Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseasesSteffen Bank, Paal Skytt Andersen, Johan Burisch, et al.
Plos One|June 28, 2014
Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohortSteffen Bank, Paal Skytt Andersen, Johan Burisch, et al.
Scandinavian Journal of Gastroenterology|July 5, 2021
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseasesMohamed Attauabi, Camilla Höglund, Janne Fassov, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up studyKonstantinos H Katsanos, Athina Tatsioni, Natalia Pedersen, et al.
Journal of Crohn'S & Colitis|January 12, 2021
Course of Disease in Patients with Microscopic Colitis: A European Prospective Incident Cohort StudyBas P M Verhaegh, Andreas Münch, Danila Guagnozzi, et al.
Journal of Crohn'S & Colitis|November 10, 2021
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level DataMohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, et al.
Pageof 5